Great Point Partners

Top Portfolio
Top Buys
Top Sells
New Buys
Exits
Neurogene Inc.
NGNE
$51.12M7.741M+1.01%+$512,155.808.56
VistaGen Therapeutics, Inc.
VTGN
$9.81M6.881.86M0%+$01.64
UroGen Pharma Ltd.
URGN
$39.31M6.372.62M0%+$06.59
Outlook Therapeutics, Inc.
OTLK
$17.67M6.321.48MNew+$17.67M2.96
OptiNose, Inc.
OPTN
$12.83M6.078.79M-0.61%-$78,286.662.15
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.